197 related articles for article (PubMed ID: 23939625)
21. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience.
Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I
Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526
[TBL] [Abstract][Full Text] [Related]
22. Cryotherapy and Radiofrequency Ablation for Eradication of Barrett's Esophagus with Dysplasia or Intramucosal Cancer.
Thota PN; Arora Z; Dumot JA; Falk G; Benjamin T; Goldblum J; Jang S; Lopez R; Vargo JJ
Dig Dis Sci; 2018 May; 63(5):1311-1319. PubMed ID: 29524114
[TBL] [Abstract][Full Text] [Related]
23. Focal endoscopic mucosal resection before radiofrequency ablation is equally effective and safe compared with radiofrequency ablation alone for the eradication of Barrett's esophagus with advanced neoplasia.
Kim HP; Bulsiewicz WJ; Cotton CC; Dellon ES; Spacek MB; Chen X; Madanick RD; Pasricha S; Shaheen NJ
Gastrointest Endosc; 2012 Oct; 76(4):733-9. PubMed ID: 22732872
[TBL] [Abstract][Full Text] [Related]
24. Predictive factors for initial treatment response after circumferential radiofrequency ablation for Barrett's esophagus with early neoplasia: a prospective multicenter study.
van Vilsteren FG; Alvarez Herrero L; Pouw RE; Schrijnders D; Sondermeijer CM; Bisschops R; Esteban JM; Meining A; Neuhaus H; Parra-Blanco A; Pech O; Ragunath K; Rembacken B; Schenk BE; Visser M; ten Kate FJ; Meijer SL; Reitsma JB; Weusten BL; Schoon EJ; Bergman JJ
Endoscopy; 2013 Jul; 45(7):516-25. PubMed ID: 23580412
[TBL] [Abstract][Full Text] [Related]
25. Biopsy depth after radiofrequency ablation of dysplastic Barrett's esophagus.
Shaheen NJ; Peery AF; Overholt BF; Lightdale CJ; Chak A; Wang KK; Hawes RH; Fleischer DE; Goldblum JR;
Gastrointest Endosc; 2010 Sep; 72(3):490-496.e1. PubMed ID: 20598302
[TBL] [Abstract][Full Text] [Related]
26. Predictive factors of radiofrequency ablation failure in the treatment of dysplastic Barrett's esophagus.
Weiss S; Pellat A; Corre F; Abou Ali E; Belle A; Terris B; Leconte M; Dohan A; Chaussade S; Coriat R; Barret M
Clin Res Hepatol Gastroenterol; 2023 Jan; 47(1):102065. PubMed ID: 36494071
[TBL] [Abstract][Full Text] [Related]
27. Clinical Outcomes Following Recurrence of Intestinal Metaplasia After Successful Treatment of Barrett's Esophagus With Radiofrequency Ablation.
Guthikonda A; Cotton CC; Madanick RD; Spacek MB; Moist SE; Ferrell K; Dellon ES; Shaheen NJ
Am J Gastroenterol; 2017 Jan; 112(1):87-94. PubMed ID: 27725648
[TBL] [Abstract][Full Text] [Related]
28. Detection and staging of esophageal cancers within Barrett's esophagus is improved by assessment in specialized Barrett's units.
Cameron GR; Jayasekera CS; Williams R; Macrae FA; Desmond PV; Taylor AC
Gastrointest Endosc; 2014 Dec; 80(6):971-83.e1. PubMed ID: 24929493
[TBL] [Abstract][Full Text] [Related]
29. Systematic review comparing radiofrequency ablation and complete endoscopic resection in treating dysplastic Barrett's esophagus: a critical assessment of histologic outcomes and adverse events.
Chadwick G; Groene O; Markar SR; Hoare J; Cromwell D; Hanna GB
Gastrointest Endosc; 2014 May; 79(5):718-731.e3. PubMed ID: 24462170
[TBL] [Abstract][Full Text] [Related]
30. Stepwise radiofrequency ablation of Barrett's esophagus preserves esophageal inner diameter, compliance, and motility.
Beaumont H; Gondrie JJ; McMahon BP; Pouw RE; Gregersen H; Bergman JJ; Boeckxstaens GE
Endoscopy; 2009 Jan; 41(1):2-8. PubMed ID: 19160152
[TBL] [Abstract][Full Text] [Related]
31. Mutations of p53 in Barrett's esophagus and Barrett's cancer: a prospective study of ninety-eight cases.
Schneider PM; Casson AG; Levin B; Garewal HS; Hoelscher AH; Becker K; Dittler HJ; Cleary KR; Troster M; Siewert JR; Roth JA
J Thorac Cardiovasc Surg; 1996 Feb; 111(2):323-31; discussion 331-3. PubMed ID: 8583805
[TBL] [Abstract][Full Text] [Related]
32. Cyclooxygenase-2 expression in esophageal epithelium before and after photodynamic therapy for Barrett's esophagus with high-grade dysplasia or intramucosal carcinoma.
Yachimski P; Mino-Kenudson M; Sherwood ME; Puricelli WP; Nishioka NS; Lauwers GY
Virchows Arch; 2011 Dec; 459(6):581-6. PubMed ID: 22081106
[TBL] [Abstract][Full Text] [Related]
33. AGA Clinical Practice Update on Endoscopic Treatment of Barrett's Esophagus With Dysplasia and/or Early Cancer: Expert Review.
Sharma P; Shaheen NJ; Katzka D; Bergman JJGHM
Gastroenterology; 2020 Feb; 158(3):760-769. PubMed ID: 31730766
[TBL] [Abstract][Full Text] [Related]
34. Prospective long-term endoscopic and histological follow-up of short segment Barrett's esophagus: comparison with traditional long segment Barrett's esophagus.
Weston AP; Krmpotich PT; Cherian R; Dixon A; Topalosvki M
Am J Gastroenterol; 1997 Mar; 92(3):407-13. PubMed ID: 9068459
[TBL] [Abstract][Full Text] [Related]
35. Properties of the neosquamous epithelium after radiofrequency ablation of Barrett's esophagus containing neoplasia.
Pouw RE; Gondrie JJ; Rygiel AM; Sondermeijer CM; ten Kate FJ; Odze RD; Vieth M; Krishnadath KK; Bergman JJ
Am J Gastroenterol; 2009 Jun; 104(6):1366-73. PubMed ID: 19491850
[TBL] [Abstract][Full Text] [Related]
36. Endoscopic features of buried Barrett's mucosa.
Yang LS; Holt BA; Williams R; Norris R; Tsoi E; Cameron G; Desmond P; Taylor ACF
Gastrointest Endosc; 2021 Jul; 94(1):14-21. PubMed ID: 33373645
[TBL] [Abstract][Full Text] [Related]
37. Barrett's esophagus: the American perspective.
Spechler SJ
Dig Dis; 2013; 31(1):10-6. PubMed ID: 23797117
[TBL] [Abstract][Full Text] [Related]
38. Transforming human papillomavirus infection and the esophageal transformation zone: prime time for total excision/ablative therapy?
Rajendra S; Sharma P
Dis Esophagus; 2019 Jul; 32(7):. PubMed ID: 31304554
[TBL] [Abstract][Full Text] [Related]
39. Management of Barrett's esophagus with dysplasia refractory to radiofrequency ablation.
Raphael KL; Trindade AJ
World J Gastroenterol; 2020 May; 26(17):2030-2039. PubMed ID: 32536772
[TBL] [Abstract][Full Text] [Related]
40. Development of Evidence-Based Surveillance Intervals After Radiofrequency Ablation of Barrett's Esophagus.
Cotton CC; Haidry R; Thrift AP; Lovat L; Shaheen NJ
Gastroenterology; 2018 Aug; 155(2):316-326.e6. PubMed ID: 29655833
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
